OTCMKTS:EXDI Exactus (EXDI) Stock Price, News & Analysis → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free EXDI Stock Alerts $0.07 -0.01 (-10.96%) (As of 10/27/2021) Add Compare Share Share Today's Range$0.05▼$0.0750-Day Range$0.07▼$0.0752-Week Range$0.04▼$0.27Volume257,300 shsAverage Volume83,144 shsMarket Capitalization$38.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Exactus alerts: Email Address Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth About Exactus Stock (OTCMKTS:EXDI)Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.Read More EXDI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXDI Stock News HeadlinesFebruary 7, 2024 | news.yahoo.comClapham chemical attack – live: Suspect Abdul Ezedi was ‘very angry’ after sister was shot deadJune 4, 2023 | investing.comStarbreeze AB B (STZEb)October 30, 2021 | finanznachrichten.deExactus Inc.: CBD Company Panacea Life Sciences Sees Promise as Denver Airport Reaches Third-Highest Passenger Traffic in WorldOctober 26, 2021 | finance.yahoo.comExactus, Inc. to Present at BIO CEO & Investor ConferenceOctober 15, 2021 | finanznachrichten.deExactus Inc.: Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversityOctober 14, 2021 | finance.yahoo.comGrand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversitySee More Headlines Receive EXDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:EXDI CUSIPN/A CIK1552189 Webwww.exactusinc.com Phone804-205-5036FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,460,000.00 Net MarginsN/A Pretax Margin-15,131.74% Return on Equity-3,272.69% Return on Assets-185.29% Debt Debt-to-Equity RatioN/A Current Ratio1.32 Quick Ratio0.82 Sales & Book Value Annual Sales$2.07 million Price / Sales18.81 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-0.72Miscellaneous Outstanding Shares599,005,000Free Float209,652,000Market Cap$38.94 million OptionableNot Optionable Beta4.21 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesEmiliano AloiPresident and Interim CEOKenneth E. PuzderChief Financial Officer and DirectorAndrew JohnsonChief Strategy OfficerBobby YampolskyInterim ChairmanKey CompetitorsBright GreenNASDAQ:BGXXNatural Alternatives InternationalNASDAQ:NAIIMannatechNASDAQ:MTEXMariMedOTCMKTS:MRMDFitLife BrandsNASDAQ:FTLFView All Competitors EXDI Stock Analysis - Frequently Asked Questions How have EXDI shares performed in 2024? Exactus' stock was trading at $0.0650 at the beginning of the year. Since then, EXDI stock has increased by 0.0% and is now trading at $0.0650. View the best growth stocks for 2024 here. When did Exactus' stock split? Exactus shares reverse split on Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. What other stocks do shareholders of Exactus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Exactus investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO). How do I buy shares of Exactus? Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EXDI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsElon’s New Device is About to Shock the WorldInvestorPlaceThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exactus Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.